All sexually active individuals with a uterus, including transgender patients, should be offered cervical screening. This patient, who is sexually active and has an intact uterus, requires regular cervical smear tests regardless of their menstrual cycle or symptoms of abnormal vaginal bleeding. Testosterone therapy may affect the patient’s gender characteristics, but gender reassignment allows for legal recognition of their gender identity and rights, such as obtaining a new birth certificate, driving license, passport, and the ability to marry in their new gender. However, neither of these factors exempts the patient from cervical screening.

Contraceptive and Sexual Health Guidance for Transgender and Non-Binary Individuals

The Faculty of Sexual & Reproductive Healthcare has released guidance on contraceptive choices and sexual health for transgender and non-binary individuals. The guidance emphasizes the importance of sensitive communication and offering options that consider personal preferences, co-morbidities, and current medications or therapies. For those engaging in vaginal sex, condoms and dental dams are recommended to prevent sexually transmitted infections. Cervical screening and HPV vaccinations should also be offered. Those at risk of HIV transmission should be advised of pre-exposure prophylaxis and post-exposure prophylaxis.

For individuals assigned female at birth with a uterus, testosterone therapy doesn’t provide protection against pregnancy, and oestrogen-containing regimens are not recommended as they can antagonize the effect of testosterone therapy. Progesterone-only contraceptives are considered safe, and non-hormonal intrauterine devices may also suspend menstruation. Emergency contraception may be required following unprotected vaginal intercourse, and either oral formulation or the non-hormonal intrauterine device may be considered.

In patients assigned male at birth, hormone therapy may reduce or cease sperm production, but the variability of its effects means it cannot be relied upon as a method of contraception. Condoms are recommended for those engaging in vaginal sex to avoid the risk of pregnancy. The guidance stresses the importance of offering individuals options that take into account their personal circumstances and preferences.

Causes of Haematospermia in a Young Adult

Haematospermia, the presence of blood in semen, can be a distressing symptom for men. In those under 40 years of age, infections are the most common cause, with sexually transmitted infections (STIs) such as chlamydia being a likely culprit, especially in the absence of urinary symptoms. Haemophilia A, a genetic disorder that affects blood clotting, is unlikely to present with haematospermia as the first symptom, especially in a young adult. Malignant hypertension, a rare and severe form of high blood pressure, can cause end-organ damage but is an unusual cause of haematospermia. Prostate cancer, which is more common in older men, can also cause haematospermia, but is usually associated with urinary symptoms and erectile dysfunction. Prostatitis, an inflammation of the prostate gland, can cause haematospermia and other symptoms such as pain and fever, but is less common than UTIs or STIs. A thorough medical history, physical examination, and appropriate investigations can help identify the underlying cause of haematospermia and guide treatment.

The NICE Feverish illness in children guidelines were introduced in 2007 and updated in 2013 to provide a ‘traffic light’ system for assessing the risk of febrile illness in children under 5 years old. The guidelines recommend recording the child’s temperature, heart rate, respiratory rate, and capillary refill time, as well as looking for signs of dehydration. Measuring temperature should be done with an electronic thermometer in the axilla for children under 4 weeks or with an electronic/chemical dot thermometer in the axilla or an infra-red tympanic thermometer. The risk stratification table categorizes children as green (low risk), amber (intermediate risk), or red (high risk) based on their symptoms. Management recommendations vary depending on the risk level, with green children managed at home, amber children provided with a safety net or referred to a specialist, and red children urgently referred to a specialist. The guidelines also advise against prescribing oral antibiotics without an apparent source of fever and note that a chest x-ray is not necessary if a child with suspected pneumonia is not being referred to the hospital.

Possible Causes of Spinal Cord Dysfunction: Symptoms and Characteristics

Spinal cord dysfunction can have various causes, each with its own set of symptoms and characteristics. Here are some possible causes and their corresponding features:

Vitamin B12 deficiency: This can lead to subacute combined degeneration of the cord, which affects the dorsal columns and pyramidal tracts. Symptoms include ataxic gait, upper motor neuron signs in the lower limbs, absent reflexes, glossitis, oral ulceration, and pale conjunctivae. Pernicious anemia, which is often autoimmune in nature, is a common underlying cause.

Human T-cell lymphotropic virus-1 infection: This retrovirus can cause T-cell lymphoma and a chronic demyelinating disease resembling multiple sclerosis. It is transmitted through sexual relations, breastfeeding, and blood transfusions. It is most prevalent in certain regions such as Central and West Africa, Japan, the Caribbean, and South America. Infection is rare in the UK, and the patient’s lack of risk factors and travel history makes it unlikely.

Anterior spinal artery thrombosis: This typically presents acutely with severe back pain and loss of pain and temperature sensations due to interruption of the spinothalamic tract. Proprioception and vibratory sensation remain intact due to the intact dorsal columns.

Epidural abscess: This often results from the spread of infection from a distant source through the blood. Symptoms include localised spinal pain, nerve root pain, paraesthesia, muscular weakness, sensory loss, sphincter dysfunction, and paralysis. Back or neck pain is usually present.

Transverse myelitis: This presents with a sensory level, usually in the mid-thoracic region, leg weakness with reduced tone and lower motor neuron signs, and incontinence.

Management of Moderate COPD

Patients with an FEV1/FVC ratio <0.70 and an FEV1 of 50-79% predicted are classified as having stage 2 moderate COPD. The initial management for such patients would be a short acting beta agonist or a short acting muscarinic antagonist. However, if symptoms persist, NICE recommends the use of a long acting beta agonist plus a long acting muscarinic antagonist. In cases where a long acting muscarinic antagonist is given, the short acting muscarinic antagonist should be stopped.

Inhaled corticosteroids alone are not recommended for moderate COPD. Instead, they should be used in combination with a long acting beta agonist as a second line treatment for patients with an FEV1 < 50%. Maintenance use of oral corticosteroid therapy in COPD is not normally recommended. Antitussive therapy is also not recommended.

Treatment for High-Risk Wounds

This man’s wound poses a high risk of contamination from horse manure, and we do not know his vaccination status. Immediate action is necessary to prevent tetanus infection. Tetanus immunoglobulin can provide short-term protection, but it takes several months to achieve long-term immunity after the first dose of tetanus vaccine and up to a week after a booster. Therefore, the patient should receive both tetanus immunoglobulin and a full course of five tetanus vaccinations, with intervals of at least four weeks between doses. The standard dose of tetanus immunoglobulin is 250 IU IM, but if the wound is heavily contaminated, or if there is a delay in seeking treatment, a dose of 500 IU is recommended.

PSA Testing and Prostate Cancer Screening

Current advice from the Department of Health states that patients should not be refused a PSA test if they request one. However, patients should be informed about the implications of the test. While there is no clear evidence to support mass prostate cancer screening, studies have shown that diagnosing patients through case presentation has led to improved cancer mortality rates in the USA. It is important to note that many patients with prostate cancer do not experience symptoms, and urinary symptoms are not always indicative of the disease. Additionally, prostate cancer can develop in patients as young as their fifth decade of life.

It is not recommended to prescribe ACE inhibitors to patients with moderate-severe aortic stenosis, making ramipril an inappropriate choice. Similarly, angiotensin-II receptor blockers like losartan are also contraindicated. Furosemide is not indicated for hypertension treatment. According to NICE CKS guidance, a combination of thiazide-like diuretics and calcium channel blockers is recommended, making indapamide a suitable alternative to ramipril and losartan. Digoxin has no role in hypertension treatment in this case.

Angiotensin-converting enzyme (ACE) inhibitors are commonly used as the first-line treatment for hypertension and heart failure in younger patients. However, they may not be as effective in treating hypertensive Afro-Caribbean patients. ACE inhibitors are also used to treat diabetic nephropathy and prevent ischaemic heart disease. These drugs work by inhibiting the conversion of angiotensin I to angiotensin II and are metabolized in the liver.

While ACE inhibitors are generally well-tolerated, they can cause side effects such as cough, angioedema, hyperkalaemia, and first-dose hypotension. Patients with certain conditions, such as renovascular disease, aortic stenosis, or hereditary or idiopathic angioedema, should use ACE inhibitors with caution or avoid them altogether. Pregnant and breastfeeding women should also avoid these drugs.

Patients taking high-dose diuretics may be at increased risk of hypotension when using ACE inhibitors. Therefore, it is important to monitor urea and electrolyte levels before and after starting treatment, as well as any changes in creatinine and potassium levels. Acceptable changes include a 30% increase in serum creatinine from baseline and an increase in potassium up to 5.5 mmol/l. Patients with undiagnosed bilateral renal artery stenosis may experience significant renal impairment when using ACE inhibitors.

The current NICE guidelines recommend using a flow chart to manage hypertension, with ACE inhibitors as the first-line treatment for patients under 55 years old. However, individual patient factors and comorbidities should be taken into account when deciding on the best treatment plan.

A pH level greater than 4.5 is linked to Trichomonas vaginalis and bacterial vaginosis.

Comparison of Bacterial Vaginosis and Trichomonas Vaginalis

Bacterial vaginosis and Trichomonas vaginalis are two common sexually transmitted infections that affect women. Bacterial vaginosis is caused by an overgrowth of bacteria in the vagina, while Trichomonas vaginalis is caused by a protozoan parasite. Both infections can cause vaginal discharge and vulvovaginitis, but Trichomonas vaginalis may also cause urethritis in men.

The vaginal discharge in bacterial vaginosis is typically thin and grayish-white, with a fishy odor. The pH of the vagina is usually higher than 4.5. In contrast, the discharge in Trichomonas vaginalis is offensive, yellow/green, and frothy. The cervix may also appear like a strawberry. The pH of the vagina is also higher than 4.5.

To diagnose bacterial vaginosis, a doctor may perform a pelvic exam and take a sample of the vaginal discharge for testing. The presence of clue cells, which are vaginal cells covered in bacteria, is a hallmark of bacterial vaginosis. On the other hand, Trichomonas vaginalis can be diagnosed by examining a wet mount under a microscope. The motile trophozoites of the parasite can be seen in the sample.

Both bacterial vaginosis and Trichomonas vaginalis can be treated with antibiotics. Metronidazole is the drug of choice for both infections. For bacterial vaginosis, a course of oral metronidazole for 5-7 days is recommended. For Trichomonas vaginalis, a one-off dose of 2g metronidazole may also be used. It is important to complete the full course of antibiotics to ensure that the infection is fully treated.

If a child has a noticeable mass in their abdomen or an unexplained enlargement of an abdominal organ, it is crucial to refer them for specialist assessment for neuroblastoma and Wilms’ tumour within 48 hours. This referral should be made urgently and not delayed by arranging imaging through general practice. Prescribing Movicol or Nitrofurantoin would not be appropriate as they do not address the underlying issue. Any child with a palpable abdominal mass should be referred to paediatrics for review as soon as possible.

Understanding Neuroblastoma in Children

Neuroblastoma is a type of cancer that affects children and is responsible for 7-8% of childhood malignancies. It develops from neural crest tissue found in the adrenal medulla and sympathetic nervous system. Typically, the disease is diagnosed in children around 20 months old and presents with a range of symptoms, including abdominal mass, weight loss, bone pain, and hepatomegaly. In some cases, paraplegia and proptosis may also occur.

To diagnose neuroblastoma, doctors will typically look for raised levels of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA). Additionally, calcification may be visible on an abdominal x-ray, and a biopsy may be necessary to confirm the diagnosis.

Overall, neuroblastoma is a serious condition that requires prompt diagnosis and treatment. By understanding the symptoms and diagnostic process, parents and caregivers can work with healthcare providers to ensure that children receive the best possible care.

Understanding Renal Calculi and Recurrent Proteus Urinary Tract Infections

Recurrent Proteus urinary tract infections (UTIs) are often associated with renal calculi, which can be detected through persistently alkaline urine and a finding of Proteus on culture. This is because Proteus organisms produce urease, which converts urea into ammonia and alkalinizes the urine, leading to the formation of organic and inorganic compounds that contribute to calculi formation.

The severity of symptoms related to renal calculi is directly proportional to the size of the stone. Smaller stones usually cause severe pain as they pass into the ureter, while larger stones such as staghorn calculi often remain asymptomatic in the kidney. A moving stone is usually more painful than a static stone.

Contrary to popular belief, most symptomatic urinary calculi originate in the upper renal tract, with the location and composition varying for different types of stones. While gallstones are composed of bile salts, renal stones are usually composed of calcium, oxalate, or uric acid.

About 75% of renal calculi are radio-opaque, meaning they can be detected through conventional KUB X-rays. However, urate and xanthine stones are radiolucent and may be too small to be detected through this method. Understanding the relationship between recurrent Proteus UTIs and renal calculi can help prompt early detection and treatment.

Referring Child Abuse Cases: A Doctor’s Responsibility

As a doctor, it is your responsibility to protect children and young people from abuse. In cases where there is ongoing risk of serious abuse, it is important to refer the child in a timely manner, even if it goes against their wishes. This is because the safety of the child should always be the top priority.

According to the General Medical Council (UK), doctors have a duty to protect children and young people from harm. Referring cases of abuse is a crucial step in ensuring their safety. It is important to act quickly and make the necessary referrals to safeguard the child’s well-being. Even if the child expresses reluctance or resistance to the referral, it is important to prioritize their safety and take appropriate action. By doing so, doctors can fulfill their responsibility to protect vulnerable children and young people from harm.

Calculation of Cost to Prevent Stroke

The calculation of the cost to prevent a stroke involves determining the absolute risk reduction and the number needed to treat. In this case, the absolute risk reduction is 4%, which means that 25 patients would need to be treated to prevent one stroke. Assuming a cost of £100 per month for 12 months, the total cost to prevent a stroke would be £30,000. This calculation is important for healthcare providers and policymakers to consider when making decisions about the allocation of resources for stroke prevention.

Treatment Considerations for Depression in Patients with Chronic Physical Health Problems

Individuals with chronic physical health problems are at a higher risk of developing depression, with a two to three times greater likelihood than those in good health. This is particularly true for patients with complications of diabetes, such as retinopathy, chronic or end-stage renal disease, and painful peripheral neuropathy, as well as those with limited mobility and independence due to osteoarthritis and severe pain.

While cognitive-behavioral therapy (CBT) is a recommended high-intensity intervention for depression, some patients may decline this treatment option. In such cases, selective serotonin reuptake inhibitors (SSRIs) are the first choice of antidepressant medication, with citalopram and sertraline being preferred options due to their lower propensity for drug interactions.

It is important to note that venlafaxine is more dangerous in overdose than other newer agents that are equally effective, and dosulepin should not be prescribed at all. Tricyclics are also associated with side effects such as blurred vision, urinary retention, constipation, and postural hypotension, which could potentially exacerbate existing health problems.

In addition to optimizing treatments for chronic diseases, healthcare providers should also consider any other medications the patient may be taking, such as aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) for arthritis, which may require gastroprotection. Overall, a comprehensive and individualized approach to treatment is necessary for managing depression in patients with chronic physical health problems.

Understanding Laryngomalacia: A Common Congenital Laryngeal Abnormality

Laryngomalacia is a congenital laryngeal abnormality that affects both sexes equally and accounts for 60-70% of cases of congenital stridor. It is characterised by the flaccidity of the supraglottic structures, resulting in a soft and floppy larynx that collapses during breathing. This condition typically presents within the first few weeks of life, with noisy respiration and inspiratory stridor.

There are three types of laryngomalacia, with type 1 involving the tightening of the aryepiglottic folds, type 2 involving redundant tissue in the supraglottic region, and type 3 being associated with other disorders such as neuromuscular weakness or gastro-oesophageal reflux disease.

The most common symptom of laryngomalacia is inspiratory stridor, which is high-pitched and crowing. This is usually intermittent and occurs in the supine position, when feeding, or when the child is agitated. While symptoms tend to increase in severity during the first 8 months, they usually resolve by 18-24 months. Respiratory distress, failure to thrive, and cyanosis are rare.

Oxygen saturation should be monitored, and blood gases taken if there is desaturation. Laryngoscopy and bronchoscopy are only indicated if there are severe features or diagnostic difficulty. In most cases, laryngomalacia resolves spontaneously by 18-24 months. Symptomatic relief may be provided by hyperextending the neck during episodes of stridor. Surgical intervention is only required with severe respiratory distress, such as tracheostomy, laryngoplasty, excision of redundant mucosa, laser epiglottopexy, or laser division of the aryepiglottic folds.

According to the Clinical Knowledge Summaries from NICE, it is recommended to utilize formal assessment tools to evaluate the extent and seriousness of alcohol misuse. This includes utilizing the AUDIT (Alcohol Use Disorders Identification Test) as a routine measure for identification purposes. This can assist in determining whether a brief intervention is necessary and, if so, what type of intervention is appropriate. In situations where time is limited, it is recommended to use a shortened version of the AUDIT, such as the AUDIT-C (AUDIT-Consumption), and then follow up with the complete questionnaire if problem drinking is indicated.

Alcohol Problem Drinking: Detection and Assessment

Alcohol problem drinking can have serious consequences on an individual’s health and well-being. Therefore, it is important to detect and assess alcohol consumption to identify those who may need intervention. Screening tools such as AUDIT, FAST, and CAGE can be used to identify hazardous or harmful alcohol consumption and alcohol dependence.

AUDIT is a 10-item questionnaire that takes about 2-3 minutes to complete. It has been shown to be superior to CAGE and biochemical markers for predicting alcohol problems. A score of 8 or more in men, and 7 or more in women, indicates a strong likelihood of hazardous or harmful alcohol consumption. A score of 15 or more in men, and 13 or more in women, is likely to indicate alcohol dependence. AUDIT-C is an abbreviated form consisting of 3 questions.

FAST is a 4-item questionnaire that can quickly identify hazardous drinking. The score for hazardous drinking is 3 or more. Over 50% of people will be classified using just the first question, which asks how often the individual has had eight or more drinks on one occasion (six or more for women).

CAGE is a well-known screening tool, but recent research has questioned its value. Two or more positive answers are generally considered a ‘positive’ result. The questions ask about feeling the need to cut down on drinking, being annoyed by criticism of drinking, feeling guilty about drinking, and having a drink in the morning to get rid of a hangover.

To diagnose alcohol dependence, the ICD-10 definition requires three or more of the following: compulsion to drink, difficulties controlling alcohol consumption, physiological withdrawal, tolerance to alcohol, neglect of alternative activities to drinking, and persistent use of alcohol despite evidence of harm.

Overall, screening and assessment tools can help identify individuals who may need intervention for alcohol problem drinking. It is important to use these tools to promote early detection and intervention to prevent further harm.

Understanding Head and Neck Cancer: Symptoms and Referral Criteria

Head and neck cancer is a broad term that encompasses various types of cancer, including oral cavity cancers, pharynx cancers, and larynx cancers. Some of the common symptoms of head and neck cancer include a persistent sore throat, hoarseness, neck lump, and mouth ulcer.

To ensure timely diagnosis and treatment, the National Institute for Health and Care Excellence (NICE) has established referral criteria for suspected cancer pathways. For instance, individuals aged 45 and above with persistent unexplained hoarseness or an unexplained lump in the neck should be referred for an appointment within two weeks to rule out laryngeal cancer.

Similarly, people with unexplained ulceration in the oral cavity lasting for more than three weeks or a persistent and unexplained lump in the neck should be referred for an appointment within two weeks to assess for possible oral cancer. Dentists should also consider an urgent referral for people with a lump on the lip or in the oral cavity or a red or red and white patch in the oral cavity consistent with erythroplakia or erythroleukoplakia.

Lastly, individuals with an unexplained thyroid lump should be referred for an appointment within two weeks to rule out thyroid cancer. By following these referral criteria, healthcare professionals can ensure that individuals with head and neck cancer receive prompt and appropriate care.

Childhood disintegration disorder

The patient exhibits hypothyroidism, indicated by low free T4 and elevated TSH levels. Considering her age, it is recommended to gradually introduce levothyroxine at a starting dose of 25mcg once daily.

Managing Hypothyroidism: Dosage, Goals, and Side-Effects

Hypothyroidism is a condition where the thyroid gland doesn’t produce enough thyroid hormone. The management of hypothyroidism involves the use of levothyroxine, a synthetic form of thyroid hormone. The initial starting dose of levothyroxine should be lower in elderly patients and those with ischaemic heart disease. For patients with cardiac disease, severe hypothyroidism, or patients over 50 years, the initial starting dose should be 25mcg od with dose slowly titrated. Other patients should be started on a dose of 50-100 mcg od. After a change in thyroxine dose, thyroid function tests should be checked after 8-12 weeks. The therapeutic goal is to achieve a ‘normalisation’ of the thyroid stimulating hormone (TSH) level, with a TSH value of 0.5-2.5 mU/l being the preferred range.

Women with established hypothyroidism who become pregnant should have their dose increased ‘by at least 25-50 micrograms levothyroxine’* due to the increased demands of pregnancy. The TSH should be monitored carefully, aiming for a low-normal value. There is no evidence to support combination therapy with levothyroxine and liothyronine.

Levothyroxine therapy may cause side-effects such as hyperthyroidism due to over-treatment, reduced bone mineral density, worsening of angina, and atrial fibrillation. Interactions with iron and calcium carbonate may reduce the absorption of levothyroxine, so they should be given at least 4 hours apart.

In summary, the management of hypothyroidism involves careful dosage adjustment, regular monitoring of thyroid function tests, and aiming for a TSH value in the normal range. Women who become pregnant should have their dose increased, and combination therapy with levothyroxine and liothyronine is not recommended. Patients should also be aware of potential side-effects and interactions with other medications.

*source: NICE Clinical Knowledge Summaries

If there is no hearing loss, it is more likely that the patient has vestibular neuronitis rather than viral labyrinthitis.

Understanding Vestibular Neuronitis

Vestibular neuronitis is a type of vertigo that typically occurs after a viral infection. It is characterized by recurrent episodes of vertigo that can last for hours or days, accompanied by nausea and vomiting. Horizontal nystagmus is also a common symptom, but there is no hearing loss or tinnitus.

It is important to differentiate vestibular neuronitis from other conditions such as viral labyrinthitis and posterior circulation stroke. The HiNTs exam can be used to distinguish between these conditions.

Treatment for vestibular neuronitis typically involves medication to alleviate symptoms, such as buccal or intramuscular prochlorperazine for severe cases, or a short course of oral medication for less severe cases. Vestibular rehabilitation exercises are also recommended for patients who experience chronic symptoms.

Understanding the symptoms and treatment options for vestibular neuronitis can help individuals manage this condition and improve their quality of life.